Monthly Archives: December 2013

Targacept and TC-5619

Targacept and TC-5619: It seems eons ago that Targacept was riding high on the wings of its TC-5214 partnership with AstraZeneca. We had hoped that their nicotinic alpha 7 entrant, TC-5619, would put them back on track, but the Phase … Continue reading

Posted in Uncategorized | 1 Comment

Roche Hits First Two of Three

Roche had been approaching a Trifecta of datasets and decision points that would determine whether their steadfast focus on innovative R&D in neuroscience would be sustained. Now, it seems certain that it will be, because the Company had success in … Continue reading

Posted in Big Pharma | Tagged , , , , , , | Leave a comment